Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP549376.RAm-lbNBKVtt43VZGDGuX90qoJXsmLXDiTh0IjZV1wKog130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549376.RAm-lbNBKVtt43VZGDGuX90qoJXsmLXDiTh0IjZV1wKog130_provenance.
• NP195274.RAgWv3NH-TqFbvk2UDZbyFL6XquGWyJUHj4ByyvSfb_ko130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP195274.RAgWv3NH-TqFbvk2UDZbyFL6XquGWyJUHj4ByyvSfb_ko130_provenance.
• NP754616.RA-sU7efIHiG5_NE4qaczbR4lOhngMj9fvVA3e7GXFZqU130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754616.RA-sU7efIHiG5_NE4qaczbR4lOhngMj9fvVA3e7GXFZqU130_provenance.
• NP680314.RAnMnBq5JLVtLFAJwPqw2zic-qtJdLFCuk7Z6mLX0xaVo130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680314.RAnMnBq5JLVtLFAJwPqw2zic-qtJdLFCuk7Z6mLX0xaVo130_provenance.
• NP363021.RAWtCx-7p2DYL087u0hZ-E3pHOL12jVPxr-BGsQLRC-Ww130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363021.RAWtCx-7p2DYL087u0hZ-E3pHOL12jVPxr-BGsQLRC-Ww130_provenance.
• NP528443.RA2Nd2zkjPHrLc9uA8mUzhowgCBq_WnvAQy-EEIA3hKWc130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528443.RA2Nd2zkjPHrLc9uA8mUzhowgCBq_WnvAQy-EEIA3hKWc130_provenance.
• NP464996.RAwXuR_Bu5Y676-DAXUvmCScFXmAWTsgICQKXNWuaJ8e8130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464996.RAwXuR_Bu5Y676-DAXUvmCScFXmAWTsgICQKXNWuaJ8e8130_provenance.
• NP528419.RAeFW3htuSGOOuGbB9WWJlMJ0eXC1iLNO6MqSB0C3JF-s130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528419.RAeFW3htuSGOOuGbB9WWJlMJ0eXC1iLNO6MqSB0C3JF-s130_provenance.
• assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP260889.RAyPlmnK9lF3KrgCpksKpenkRf4medKqnflnFuaTgh0xA130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260889.RAyPlmnK9lF3KrgCpksKpenkRf4medKqnflnFuaTgh0xA130_provenance.
• NP260884.RAdgNF0XsIYTOjveGGWHzAEgtEzXE_W46falXQULQGigE130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260884.RAdgNF0XsIYTOjveGGWHzAEgtEzXE_W46falXQULQGigE130_provenance.
• assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP260883.RAFF-jivadM1ZeN5iqTOpUoSCiD9sZXpmy_QCyAYsYyZ8130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260883.RAFF-jivadM1ZeN5iqTOpUoSCiD9sZXpmy_QCyAYsYyZ8130_provenance.
• NP260887.RAG44vCwtDd7PtL3lwKDp7sIyngq5nUXi1bjDLYfzmfNg130_assertion description "[Using a transgenic mouse model expressing the E2F1 gene under the control of a keratin 5 (K5) promoter, we previously demonstrated that increased E2F1 activity can promote tumorigenesis by cooperating with either a v-Ha-ras transgene to induce benign skin papillomas or p53 deficiency to induce spontaneous skin carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260887.RAG44vCwtDd7PtL3lwKDp7sIyngq5nUXi1bjDLYfzmfNg130_provenance.